20 May 2013
Keywords: Astellas, Kiklin, Hyperphosphatemia, Japan, Sanwa Kagaku
Article | 26 June 2012
Japanese drug major Astellas Pharma (TYO: 4503) yesterday launched Kiklin capsules 250mg (bixalomar) onto the Japanese market for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 June 2012
© 2013 thepharmaletter.com